Delivery Order SPE2DB20D1004-SPE2DB25FNJWP
- Not listed
- The Defense Logistics Agency awarded a $10,308.12 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Eliquis 5 mg tablets (60-count packages). This is a firm fixed price, non-set-aside contract with a completion date of July 22, 2025, and performance location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a relatively small transaction within the company's extensive federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 units, with a ceiling value of $9,366.47. This competitive, firm fixed-price delivery order is expected to be completed by August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,591.08 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packaging) on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's existing contract...
- The Defense Logistics Agency awarded a delivery order valued at $8,582.92 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packaging) on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) valued at $3,271.68 with a firm fixed price structure and an ultimate completion date of August 12, 2025. This is a non-set-aside, competitively awarded delivery order executed under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), which is valued at $999.999 billion and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,703.72 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages). This competitive award, issued on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 units. This $23,630.04 firm fixed price delivery order represents a non-set-aside, competitively awarded contract with a completion date of July 31, 2025. The order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued...
- On August 11, 2025, the Defense Logistics Agency awarded a delivery order valued at $40,304.74 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets in quantities of 60. This competitively awarded, firm fixed-price delivery order is set to be completed by August 12, 2025, with fulfillment occurring at the contractor's location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Eliquis 5 mg tablets in a 60-count package, valued at $12,551.21. This firm fixed-price delivery order is scheduled for completion by August 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the contractor's demonstrated...
- The Defense Logistics Agency awarded a delivery order valued at $15,801.10 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed-price contract type. The award was made on August 5, 2025, with an ultimate completion date of August 6, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania serves as the place of performance for this...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB25FNJWPDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,736.50 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Eliquis 5 mg tablets (60-count units). This is a firm fixed price delivery order with no set-aside designation, representing a competitive award under the company's existing contract vehicle. Performance will be completed by August 6, 2025, and the pharmaceutical supplies will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical supply vehicle running through December 2026. As a prime vendor for federal military healthcare procurement, AmerisourceBergen supplies a comprehensive range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support military and veteran healthcare systems. The DLA utilizes this contract vehicle to ensure reliable access to critical pharmaceuticals for Defense Health Agency customers, the U.S. Coast Guard, and other federal healthcare entities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.7k | 8/5/25 |